The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

BioTalk Unzipped

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

Summary

In Episode 13, Jason Burke discusses the unique approach of the Duke program in providing real-world healthcare data to students. He also highlights the breakthrough in AI-generated drug discovery and its potential impact on investors and startups. The process of assessing technologies for companies and patients is explored, with a focus on evaluating business and technology aspects. The importance of unique intellectual property is emphasized, and the future of AI and software is discussed. The conversation concludes with insights into using AI in everyday life and the role of search engine companies in AI. In this conversation, Chad and Jason discuss the interface between pharma companies and the healthcare industry, highlighting the lack of interplay between the two. They explore the challenges faced by the healthcare industry, including the complexity of the operating environment and the limited infrastructure for research. Jason emphasizes the potential for life sciences firms to become service companies and overcome these challenges. They also delve into Jason's interest in amateur radio and the fascinating world of ham radio, where he has been learning and discovering new things.

Takeaways

• The Duke program provides students with real-world healthcare data, giving them a unique advantage in the job market.

• AI-generated drug discovery has the potential to revolutionize the pharmaceutical industry and attract more investment to startups.

• Assessing technologies for companies and patients involves evaluating both the business and technology aspects, including intellectual property.

• The future of AI and software will see the emergence of new forms of experiences and collaboration between humans and machines.

• Search engine companies have been late to adopt AI technologies like ChatGPT, but they have already been utilizing AI in their search algorithms.

• \There is a need for more interplay between pharma companies and the healthcare industry to ensure better understanding of customer needs and feedback.

• The healthcare industry faces challenges due to the complexity of the operating environment and limited infrastructure for research.

• Life sciences firms have the potential to become not just product companies, but service companies and provide valuable solutions to overcome the challenges in the healthcare industry.

• Doctors want to help patients at the highest level possible but continually grapple with the complexity of the healthcare environment and the sheer volume of patients.

• Amateur radio, or ham radio, offers a fascinating world of learning and discovery, with a community of innovators constantly finding new and creative ways to use the technology.

Chapters

00:29 Unique Approach in Duke Program

05:14 New News! The First AI-Generated Drug Discovery

09:33 Assessing Technologies for Companies and Patients.

11:52 The Importance of Unique Intellectual Property

12:35 The Future of AI and Software

13:36 Data as a Commodity

15:10 Innovation Curves and Technology, AI Compressing it

16:41 Using AI in Everyday Life

19:04 Why were Search Engine Companies Late to the Generative AI Game?

20:05 New Forms of Software and Experiences

22:53 The Future of Healthcare and Pharma - Enough Interfacing?

25:08 The Difficulty of Doctors in Complex Environments and Implementing Precision Medicine

29:03 Jason's Interest in Amateur Radio and Exploring the Ham Radio Community

31:39 Bouncing a Radio Signal Off the Moon & Sending Emails over Radio Waves

How to reach us:

Jason Burke

https://www.linkedin.com/in/jasonburke/

Creo Inc. - https://www.creoinc.net/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com/

#AI #pharmaceutical #healthcare #drugdiscovery #futuretech #lifesciences